Surgepays is trading 6.82% down at $0.13, with no confirmed company-specific announcement located for October 23, 2026.

  • The latest company news found was the October 15 GrowthLine partner-brand announcement, not a new catalyst for the decline.
  • Broader risk-off sentiment may be a factor: market coverage cites AI-spending concerns and rising oil prices, while the Dow is down 1.04%.